Sponsor:
The Brooklyn Hospital Center
Code:
NCT03221569
Conditions
Migraine
Eligibility Criteria
Sex: Male
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
Intravenous ketamine
Ketorolac
Normal saline
Normal saline
Brief summary:
Conditions
Migraine
Study ID
NCT03221569
Start date
Feb 1, 2016
Status verified date
Jul, 2018
Completion date
Feb 1, 2020
Anticipated
Primary completion date
Feb 1, 2020
Anticipated
Eligibility Criteria
Sex: Male
Age: 18 - 65
Healthy Volunteers: Not accepted
Enrollment
60 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Intravenous ketamine
active comparator: ketorolac
Interventions
Intravenous ketamine
Ketorolac
Normal saline
Normal saline
Primary outcome measure
Central contacts
Locations
The Brooklyn Hospital Center
Recruiting
Brooklyn, New York, United States, 11201
Contacts
Billy W Sin, Pharm.D.
718-250-6250Sponsor
The Brooklyn Hospital Center
Last update posted
Jul 6, 2018
Last verified
Jul, 2018
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by The Brooklyn Hospital Center on 2018-07-06.